
Naltrexone Contraindications: Opioids, Withdrawal, and Label Checks
Current opioid use, opioid dependence, acute withdrawal, specified test results, and prior hypersensitivity can make naltrexone unsafe to start.
An independent guide to naltrexone for alcohol and opioid use disorder. Compare tablets with the monthly injection, check when it is safe to start, and follow the prescription and funding routes in eight countries.
Independent and ad-free, with no sponsors or affiliate links. Peter Dunk writes the guides from medicine labels and national guidelines, and Dr Leonard Leng has medically reviewed our articles.
Choose the question closest to yours. You do not need to read the site in order.
See how it blocks opioid receptors, why that can help with alcohol or opioid treatment, and what it does not do.
Recent opioid use is the first issue to raise. Even some pain, cough, and diarrhoea medicines can matter before the first dose.
Compare daily oral naltrexone with extended-release Vivitrol without treating them as interchangeable products.
Country guides show the product, funding, and care routes we could verify—and the questions only a local service can answer.
A medicine can be clinically recognised yet difficult to find, unfunded, or available only in a different formulation. Pick your country for the practical route.
These clear up many of the confusing or contradictory claims found online.
Focused guides to starting safely, comparing medicines, and understanding evidence without the medical-journal voice.

Current opioid use, opioid dependence, acute withdrawal, specified test results, and prior hypersensitivity can make naltrexone unsafe to start.

Naltrexone can trigger severe withdrawal if opioids are still present. The minimum interval is not a self-assessment rule and may be longer after buprenorphine or methadone.

Nausea, headache, dizziness, and tiredness are reported with naltrexone. Vivitrol also has injection-site effects; certain symptoms need prompt clinical review.

Vivitrol is prepared and given only by a healthcare provider as a deep gluteal injection. This guide explains the patient-facing safety essentials.
Choose your country to see which product and care pathway are documented, then use the page’s questions when you speak with a clinician, pharmacist, or insurer.